Suspended
Comparison of 18-F Sodium Fluoride Uptake in Culprit Plaques Between Acute Coronary Syndrome and Stable Angina
What is being tested
18-F Sodium Fluoride Uptake in Positron emission tomography
Other
Who is being recruted
Angina Pectoris+13
+ Arterial Occlusive Diseases
+ Arteriosclerosis
Over 21 Years
+9 Eligibility Criteria
How is the trial designed
Diagnostic Study
Interventional
Study Start: August 2012
Summary
Principal SponsorCHEOL WHAN LEE, MD, PhD.
Last updated: July 28, 2014
Sourced from a government-validated database.Claim as a partner
Study start date: August 1, 2012
Actual date on which the first participant was enrolled.The purpose of this study is to evaluate the correlations between active calcification and vulnerable plaque.
Principal SponsorCHEOL WHAN LEE, MD, PhD.
Last updated: July 28, 2014
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
20 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Diagnostic Study
Diagnostic studies focus on improving how we detect or confirm a disease. They test new tools or techniques that could provide faster or more accurate diagnoses.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 21 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Angina PectorisArterial Occlusive DiseasesArteriosclerosisCardiovascular DiseasesChest PainCoronary DiseaseHeart DiseasesNeurologic ManifestationsPainSigns and SymptomsPathological Conditions, Signs and SymptomsVascular DiseasesMyocardial IschemiaCoronary Artery DiseaseAcute Coronary SyndromeAngina, Stable
Criteria
2 inclusion criteria required to participate
Acute coronary syndrome or stable angina
Age more than 20
7 exclusion criteria prevent from participating
Acute ST segment elevation myocardial infarction within 12hours, heart failure, cardiac shock
Any serious medical comorbidity such that the subject's life expectancy is less than 24 months
Contraindications to the use of heparin, aspirin, clopidogrel, stainless metal, contrast media
Ejection fraction less than 30
Show More Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
SuspendedOne Study Center